300639 凱普生物
按盤價 
6.000 +0.160 (+2.740%)
6.000 +0.160 (+2.740%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -5.603 | 2.876 | 42.609 | 30.516 | 20.889 |
| 總資產報酬率 ROA (%) | -4.842 | 2.254 | 31.460 | 24.044 | 17.461 |
| 投入資產回報率 ROIC (%) | -5.434 | 2.764 | 40.125 | 28.793 | 20.296 | 邊際利潤分析 |
| 銷售毛利率 (%) | 53.814 | 61.029 | 69.364 | 67.633 | 73.366 |
| 營業利潤率 (%) | -74.860 | 3.857 | 39.185 | 40.171 | 34.614 |
| 息稅前利潤/營業總收入 (%) | -77.767 | 2.291 | 37.968 | 39.693 | 34.048 |
| 淨利潤/營業總收入 (%) | -65.665 | 6.203 | 32.193 | 33.106 | 29.137 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 14.865 | 17.449 | 130.114 | 103.498 | 101.699 |
| 價值變動淨收益/利潤總額(%) | -1.913 | 37.870 | 1.003 | 1.949 | 1.148 |
| 營業外收支淨額/利潤總額(%) | 0.789 | -15.710 | -3.069 | -1.570 | -1.048 | 償債能力分析 |
| 流動比率 (X) | 6.549 | 6.255 | 3.229 | 3.767 | 6.475 |
| 速動比率 (X) | 6.318 | 6.059 | 3.142 | 3.550 | 6.157 |
| 資產負債率 (%) | 10.041 | 10.951 | 22.454 | 17.875 | 0.113 |
| 帶息債務/全部投入資本 (%) | 1.832 | 0.729 | 2.261 | 4.518 | 3.253 |
| 股東權益/帶息債務 (%) | 5,268.510 | 13,367.960 | 4,194.715 | 2,062.472 | 2,949.580 |
| 股東權益/負債合計 (%) | 877.619 | 775.256 | 324.196 | 422.329 | 740.824 |
| 利息保障倍數 (X) | 33.635 | -2.198 | -755.637 | 278.471 | -165.019 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 721.189 | 751.262 | 123.204 | 113.309 | 120.417 |
| 存貨周轉天數 (天) | 89.722 | 91.291 | 27.911 | 50.649 | 69.714 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 04/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
